LLY vs TMO
By Alex · Tickerpine
Eli Lilly and Company vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | TMO |
|---|---|---|
| Price | $1,208.12 | $513.03 |
| Market cap | $1.08T | $190.65B |
| P/E ratio | 42.9 | 28.2 |
| ROE | 107.46% | 13.52% |
| Profit margin | 34.99% | 15.15% |
| Revenue growth | 55.50% | 6.20% |
| Dividend yield | 0.57% | 0.37% |
| Beta | 0.52 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs TMO in plain English
- LLY is the bigger company — about 5.7× the market cap of TMO.
- TMO is cheaper on earnings (P/E 28.2 vs 42.9).
- LLY earns a higher return on equity (107% vs 14%).
- LLY is growing revenue faster (56% vs 6%).
- LLY has the higher dividend yield (0.57% vs 0.37%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.